Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Cash & Current Investments: 2018-2020

Historic Cash & Current Investments for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to -$613.5 million.

  • Genmab A's Cash & Current Investments fell 63.39% to -$676.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$1.7 billion, marking a year-over-year increase of 14.09%. This contributed to the annual value of -$613.5 million for FY2020, which is 110.01% down from last year.
  • As of FY2020, Genmab A's Cash & Current Investments stood at -$613.5 million, which was down 110.01% from -$292.1 million recorded in FY2019.
  • Genmab A's 5-year Cash & Current Investments high stood at -$292.1 million for FY2019, and its period low was -$613.5 million during FY2020.
  • Over the past 3 years, Genmab A's median Cash & Current Investments value was -$330.4 million (recorded in 2018), while the average stood at -$412.0 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first climbed by 11.58% in 2019, then slumped by 110.01% in 2020.
  • Over the past 3 years, Genmab A's Cash & Current Investments (Yearly) stood at -$330.4 million in 2018, then rose by 11.58% to -$292.1 million in 2019, then crashed by 110.01% to -$613.5 million in 2020.